ArticleAnnals of family medicine2017
Health Benefits and Cost-Effectiveness of Brief Clinician Tobacco Counseling for Youth and Adults.
Article in Annals of family medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 7 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 7 syntheses or guidelines pooled it, 46 citations in OpenAlex.
- Guideline
- Recommendations on interventions for tobacco smoking cessation in adults in Canada.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2025Guideline
- Strategies to improve the implementation of preventive care in primary care: a systematic review and meta-analysis.BMC medicine · 2024Pooled it
- Identifying best modelling practices for tobacco control policy simulations: a systematic review and a novel quality assessment framework.Tobacco control · 2023Pooled it
- Pooled it
- Motivational support intervention to reduce smoking and increase physical activity in smokers not ready to quit: the TARS RCT.Health technology assessment (Winchester, England) · 2023Pooled it
- Wearable Sensors for Monitoring of Cigarette Smoking in Free-Living: A Systematic Review.Sensors (Basel, Switzerland) · 2019Pooled it
- A Randomized Controlled Trial of an Optimized Smoking Treatment Delivered in Primary Care.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2018Trial
- Association of Communication With Smoking Attitudes and Behaviors Among Patients Undergoing Lung Cancer Screening: A Longitudinal Cohort Study.CHEST pulmonary · 2025Article
- Illuminating a Path Forward for Tobacco Nation: Projected Impacts of Recommended Policies on Geographic Disparities.Tobacco use insights · 2023Article
- "It's a decision I have to make": Patient perspectives on smoking and cessation after lung cancer screening decisions.Preventive medicine reports · 2022Article
- The Cost-Effectiveness of Nicotine Replacement Therapy Sampling in Primary Care: a Markov Cohort Simulation Model.Journal of general internal medicine · 2022Article
- Personalized Disease Prevention (PDP): study protocol for a cluster-randomized clinical trial.Trials · 2022Article
- Validation of the Prevention Impacts Simulation Model (PRISM).Preventing chronic disease · 2021Article
- Nicotine and Opioids: a Call for Co-treatment as the Standard of Care.The journal of behavioral health services & research · 2020Review
- Twenty-year health and economic impact of reducing cigarette use: Minnesota 1998-2017.Tobacco control · 2020Article
- The 20-year impact of tobacco price and tobacco control expenditure increases in Minnesota, 1998-2017.PloS one · 2020Article
- Igniting activation: Using unannounced standardized patients to measure patient activation in smoking cessation.Addictive behaviors reports · 2019Article
- Trends in Utilization, Spending, and Prices of Smoking-Cessation Medications in Medicaid Programs: 25 Years Empirical Data Analysis, 1991-2015.American health & drug benefits · 2018Article
- Long-Term Outcomes From Repeated Smoking Cessation Assistance in Routine Primary Care.American journal of health promotion : AJHP · 2018Observational
Corrections and comments
- Commented on by
Authors and funding
7 authors at 1 institution in 1 country.
Funding
Abstract
purposeTo help clinicians and care systems determine the priority for tobacco counseling in busy clinic schedules, we assessed the lifetime health and economic value of annually counseling youth to discourage smoking initiation and of annually counseling adults to encourage cessation.
methodsWe conducted a microsimulation analysis to estimate the health impact and cost effectiveness of both types of tobacco counseling in a US birth cohort of 4,000,000. The model used for the analysis was constructed from nationally representative data sets and structured literature reviews.
resultsCompared with no tobacco counseling, the model predicts that annual counseling for youth would reduce the average prevalence of smoking cigarettes during adult years by 2.0 percentage points, whereas annual counseling for adults will reduce prevalence by 3.8 percentage points. Youth counseling would prevent 42,686 smoking-attributable fatalities and increase quality-adjusted life years (QALYs) by 756,601 over the lifetime of the cohort. Adult counseling would prevent 69,901 smoking-attributable fatalities and increase QALYs by 1,044,392. Youth and adult counseling would yield net savings of $225 and $580 per person, respectively. If annual tobacco counseling was provided to the cohort during both youth and adult years, then adult smoking prevalence would be 5.5 percentage points lower compared with no counseling, and there would be 105,917 fewer smoking-attributable fatalities over their lifetimes. Only one-third of the potential health and economic benefits of counseling are being realized at current counseling rates.
conclusionsBrief tobacco counseling provides substantial health benefits while producing cost savings. Both youth and adult intervention are high-priority uses of limited clinician time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.